Aerie Pharmaceuticals
AERI
$15.25
Share price
0.00%
Change (1 day)
83.73%
Change (1 year)
Categories
P/S ratio for Aerie Pharmaceuticals (AERI)
P/S ratio as of May 2024 (TTM): 3.52
According to Aerie Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.52254. At the end of 2022 the company had a P/S ratio of 3.49.
P/S ratio history for Aerie Pharmaceuticals from 2014 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 3.49 | 99.48% |
| 2021 | 1.75 | -76.98% |
| 2020 | 7.61 | -52.65% |
| 2019 | 16.1 | -76.33% |
| 2018 | 67.9 | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Merck MRK | 5.40 | 53.43% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | 347 | 9,761.86% | 🇺🇸 USA |
 Insmed INSM | 12.5 | 254.56% | 🇺🇸 USA |